Small molecules targeting canonical transient receptor potential channels: an update

Drug Discov Today. 2024 Mar 20:103951. doi: 10.1016/j.drudis.2024.103951. Online ahead of print.ABSTRACTTransient receptor potential canonical (TRPC) channels belong to an important class of non-selective cation channels. This channel family consists of multiple members that widely participate in various physiological and pathological processes. Previous studies have uncovered the intricate regulation of these channels, as well as the spatial arrangement of TRPCs and the binding sites for various small molecule compounds. Multiple small molecules have been identified as selective agonists or inhibitors targeting different subtypes of TRPC, including potential preclinical drug candidates. This review covers recent advancements in the understanding of TRPC regulation and structure and the discovery of TRPC small molecules over the past few years, with the aim of facilitating research on TRPCs and small-molecule drug discovery.PMID:38514041 | DOI:10.1016/j.drudis.2024.103951
Source: Drug Discovery Today - Category: Drugs & Pharmacology Authors: Source Type: research